Renalytix plc (NASDAQ: RNLX)
$0.34
+0.0092 ( +2.79% ) 1.5M
Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the common and costly chronic medical conditions globally. The company's product is KidneyIntelX which is being designed to make improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.
Market Data
Open
$0.34
Previous close
$0.33
Volume
1.5M
Market cap
$26.54M
Day range
$0.28 - $0.35
52 week range
$0.22 - $3.66
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 13 | Dec 29, 2023 |
8-k | 8K-related | 15 | Dec 18, 2023 |
8-k | 8K-related | 13 | Dec 18, 2023 |
8-k | 8K-related | 13 | Dec 08, 2023 |
4 | Insider transactions | 1 | Nov 22, 2023 |
4 | Insider transactions | 1 | Nov 22, 2023 |
4 | Insider transactions | 1 | Nov 22, 2023 |
4 | Insider transactions | 1 | Nov 22, 2023 |
4 | Insider transactions | 1 | Nov 22, 2023 |
ars | Annual reports | 1 | Nov 17, 2023 |